fashion -WSS

fashion

author：Wikipedia 2025-09-29 23:12:23 - browse：3289

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Vertex Pharmaceuticals may move headquarters in Boston

The Readout: Lenmeldy, GLP

ARCH Venture Partners is raising $3 billion for a life sciences fund

Novo Nordisk to expand supply of Wegovy for U.S. patients

focus

fashion

knowledge

Cancer drug shortages should be causing more outrage

A $475,000 price tag for a new cancer drug: crazy or meh?

How to save PrEP access — and even expand it

What we need to know about Arena Bioworks

United colonoscopy coverage change 'may cost lives,' doctors say

Juul spent big to court Black leaders to promote its e

After affirmative action ruling, medical educators look to 'holistic review'

Quicker fix for pulse oximeters urged during FDA public meeting

Medical records are filled with copy

FDA's naming rule on biosimilars has undermined competition

explore

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Commercial surrogacy can be ethical, despite pope’s claims

Supreme Court mifepristone arguments center on docs' right to sue

Medicare drug price negotiation’s day in court

Cognito secures funding to test medical device for Alzheimer's

focus

explore

explore

entertainment